Biogen says it will not give up on Alzheimer’s after failed trials
April 24, 2019 at 13:42 PM EDT
Biogen Inc. executives sought on Wednesday to ease investors’ concerns over the recent failure of one of the company’s investigational Alzheimer's drugs.